Next Treatments
Back to Eczema

ASN008

TypeTopical StagePhase 2 Latest updateDec 27, 2024Phase 2 results posted

Results

Trial: NCT05870865
Mean Change From Baseline in EASI ScoreAfter 4 weeks
ASN008 Matching Vehicle30 people
3 lower
ASN008 1.25%32 people
3 lower
ASN008 2.5%28 people
4 lower
ASN008 5%25 people
3 lower
01020
NCT05870865 · Ages 18+ · Results posted Dec 2024 · This is a summary of trial data for informational purposes only. It is not medical advice.
What is EASI?
  • EASI stands for Eczema Area and Severity Index.
  • This outcome measure evaluates the change and percent change in the Eczema Area and Severity Index (EASI) score from Baseline to Week 4. The EASI score measures the extent and severity of eczema across four body regions: head/neck, trunk, upper limbs, and lower limbs.As this trial registered it · NCT05870865 (the full definition is there)
Why this trial?

ASN008 has one trial with posted results, and NCT05870865 compared the drug with placebo on a result this page charts.

History

Earliest recorded event: Jan 14, 2019. This timeline shows events collected by Eczema Radar and may not include the treatment’s full history. Study details reflect the latest registry record available here.

  • Dec 27, 2024Phase 2 results postedA Study to Evaluate the Anti-pruritic Effectiveness of ASN008 in Adults With Mild to Moderate Atopic Dermatitis ClinicalTrials.gov NCT05870865
  • Dec 28, 2023Phase 2 trial completedA Study to Evaluate the Anti-pruritic Effectiveness of ASN008 in Adults With Mild to Moderate Atopic Dermatitis ClinicalTrials.gov NCT05870865
  • Nov 27, 2023Phase 2 main data collectedA Study to Evaluate the Anti-pruritic Effectiveness of ASN008 in Adults With Mild to Moderate Atopic Dermatitis ClinicalTrials.gov NCT05870865
  • May 3, 2023Phase 2 trial startedA Study to Evaluate the Anti-pruritic Effectiveness of ASN008 in Adults With Mild to Moderate Atopic Dermatitis ClinicalTrials.gov NCT05870865
  • Mar 20, 2020Phase 1 trial completedStudy to Evaluate ASN008 Topical Gel (TG) ClinicalTrials.gov NCT03798561
  • Jan 14, 2019Phase 1 trial startedStudy to Evaluate ASN008 Topical Gel (TG) ClinicalTrials.gov NCT03798561

Sources

Trials